Global Prevalence of Congenital Heart Disease at High Altitude ~9 Percent
THURSDAY, Sept. 26, 2024 -- The global prevalence of congenital heart disease (CHD) at high altitude is 8.97 percent, according to the results of a review presented at the American College of Cardiology Latin America 2024, held from Sept. 19 to 21 in Punta Cana, Dominican Republic.
Jean Pierre Eduardo Zila Velasque, from Red Latinoamericana de Medicina en la Altitud e Investigación in Peru, and colleagues conducted a systematic literature review to globally characterize CHD in populations based at different altitudinal levels.
Based on data from 22 studies (roughly 1.18 million participants from eight different countries), the researchers found that the prevalence of CHD in the general population was 8.97 percent and was higher in women. The global prevalence varied by altitude: 6.80 percent at 1,500 to 2,500 m, 14.47 percent at 2,500 to 3,500 m, 7.26 percent at 3,500 to 4,500 m, and 1.52 percent at 4,500 m. Atrial septal defect (29.9 percent) was the most frequent heart disease. Rural environments (7.86 percent), native people (12.70 percent), and American countries (32.44 percent) showed higher prevalence.
"The evidence on congenital heart disease is underestimated and underdiagnosed; due to, poor access to the health system or health systems without the essential tools that are characteristic of high-altitude environments; raising concerns that we are likely facing much higher altitude-associated congenital heart disease values than is known," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in...
Urine Biomarker Panel Sensitive, Specific for Prostate Cancer Diagnosis
THURSDAY, Sept. 11, 2025 -- A urine-based biomarker panel has high accuracy for diagnosing prostate cancer (PCa), according to a study published in the September issue of...
Hospitals Vary in Their Definition of Blood Culture Contamination
THURSDAY, Sept. 11, 2025 -- U.S. hospitals vary in how they define blood culture contamination (BCC), according to a study published online July 11 in the Journal of Clinical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.